A Nevada judge denied two motions from Genentech Inc. and parent company Roche to dismiss a PDL BioPharma lawsuit centering on royalties from a 2003 deal, PDL said.
Judge David Hardy also dismissed a claim by PDL (NASDAQ: PDLI), which was based in Redwood City before moving late 2008 to Incline Village, Nev., that Genentech breached an implied covenant of good faith and fair dealing.
The rulings are the latest in a court battle following an August 2010 letter from South San Francisco-based Genentech that claimed that PDL’s technique for humanizing an antibody does not apply to drugs Roche sells in Europe.
No comments:
Post a Comment